A new study finds an increase in transcription factor TOX2 in people with natural killer/T-cell lymphoma.

"We hypothesized that the newer treatment would turn out to be most beneficial for patients, but the magnitude of the benefit exceeded our expectations."

A new substance may treat staph infections in people with skin lymphoma. That's good news for patients and fighting antibiotic resistance.

New research on cat and dog health may provide clues on how to prevent and treat cancer in humans.

A new shingles vaccine may work where others have failed for patients with lymphoma, researchers report.

When levels of the protein are low, the immune system is "unleashed," which can kickstart a rare form of lymphoma.